Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 184.108.40.206. If your access is via an institutional subscription, please contact your librarian to request reinstatement. If you are using a personal subscription, please contact the Duke University Press using the Contact Us form.
This article examines private industry's involvement in the area of clinical laboratory testing, as an example of the relationship between the increased cost of medical care and increased involvement of private industry in the health care sector. After tracing the history of corporate and technological development in the clinical laboratory field, and particularly in the area of blood chemistry analysis, the article suggests some implications for public policy of the current state of affairs.